HV Capital, a leading European venture capital firm, has successfully closed its €710M fund amidst the wider European and global funding downturn. The fund will be used to invest in early-stage technology companies across Europe.
The closing of this new fund is an impressive feat given the current economic climate in Europe and beyond. Despite the difficult market conditions, HV Capital was able to secure commitments from both existing investors as well as new ones who saw potential in their strategy and approach.
This latest round of investment brings HV’s total assets under management (AUM) to over €1 billion for the first time – a testament to their success since launching just three years ago. The company plans on using these funds primarily for investments into early-stage startups with disruptive technologies that can make an impact on society at large or create significant value for shareholders over time.
In addition, they plan on leveraging their experience with successful exits, such as those achieved by previous portfolio companies like Fintech startup N26, which recently went public via SPAC listing earlier this year; and health tech startup Doctolib, which had one of Europe’s largest tech IPOs last year valuing it at more than USD 4Bn post-listing.
Overall, despite challenging times ahead due to COVID-19-related disruptions; HV Capital remains optimistic about what lies ahead thanks largely due to its strong investor base combined with experienced team members who have proven track records when it comes to investing in innovative startups across multiple sectors.
Read more at TechCrunch
